Merck Gross Margin 2010-2024 | MKKGY

Current and historical gross margin for Merck (MKKGY) over the last 10 years. The current gross profit margin for Merck as of June 30, 2024 is %.
Merck Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-06-30 $22.58B $13.15B 58.23%
2024-03-31 $22.60B $13.12B 58.04%
2023-12-31 $22.72B $13.41B 59.03%
2023-09-30 $22.91B $13.76B 60.06%
2023-06-30 $23.13B $14.17B 61.26%
2023-03-31 $23.27B $14.40B 61.88%
2022-12-31 $23.42B $14.44B 61.64%
2022-09-30 $23.58B $14.70B 62.33%
2022-06-30 $23.60B $14.69B 62.24%
2022-03-31 $23.54B $14.69B 62.39%
2021-12-31 $23.29B $14.59B 62.66%
2021-09-30 $22.79B $14.20B 62.32%
2021-06-30 $22.12B $13.65B 61.71%
2021-03-31 $20.79B $12.73B 61.24%
2020-12-31 $20.03B $12.22B 61.02%
2020-09-30 $19.42B $11.87B 61.12%
2020-06-30 $18.73B $11.61B 62.00%
2020-03-31 $18.66B $11.68B 62.59%
2019-12-31 $18.09B $11.36B 62.82%
2019-09-30 $17.42B $10.98B 63.01%
2019-06-30 $17.27B $10.91B 63.15%
2019-03-31 $17.24B $10.93B 63.43%
2018-12-31 $17.52B $11.17B 63.72%
2018-09-30 $17.87B $11.47B 64.18%
2018-06-30 $17.90B $11.53B 64.43%
2018-03-31 $17.75B $11.49B 64.76%
2017-12-31 $17.32B $11.31B 65.30%
2017-09-30 $16.90B $11.10B 65.67%
2017-06-30 $16.68B $11.01B 65.99%
2017-03-31 $16.70B $11.00B 65.90%
2016-12-31 $16.63B $10.87B 65.38%
2016-09-30 $16.29B $10.71B 65.74%
2016-06-30 $15.63B $10.40B 66.53%
2016-03-31 $14.89B $10.02B 67.30%
2015-12-31 $14.31B $9.78B 68.38%
2015-09-30 $13.91B $9.36B 67.29%
2015-06-30 $14.32B $9.56B 66.73%
2015-03-31 $14.59B $9.81B 67.25%
2014-12-31 $14.78B $10.09B 68.26%
2014-09-30 $15.11B $10.64B 70.46%
2014-06-30 $14.86B $10.69B 71.98%
2014-03-31 $14.80B $10.77B 72.79%
2013-12-31 $14.72B $10.75B 73.02%
2013-09-30 $14.64B $11.73B 80.08%
2013-06-30 $14.55B $11.61B 79.77%
2013-03-31 $14.30B $11.32B 79.17%
2012-12-31 $14.00B $11.97B 85.54%
2012-09-30 $13.66B $11.64B 85.19%
2012-06-30 $13.69B $12.65B 92.42%
2012-03-31 $13.85B $12.75B 92.10%
2011-12-31 $14.08B $12.98B 92.23%
2011-09-30 $14.47B $13.38B 92.44%
2011-06-30 $14.03B $12.14B 86.50%
2011-03-31 $13.05B $12.25B 93.87%
2010-12-31 $12.34B $11.54B 93.52%
2010-09-30 $11.61B $10.81B 93.11%
2010-06-30 $11.25B $11.25B 100.00%
2010-03-31 $11.14B $11.14B 100.00%
2009-12-31 $10.81B $10.81B 100.00%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00